1 of 51

Study Design and Analysis in Epidemiology: ��Where does modelling fit?

MMED 2025

Carl

​

​

Earlier contributors: Cari van Schalkwyk & Steve Bellan

Slide Set Citation: DOI:10.6084/m9.figshare.5038784

The ICI3D Figshare Collection

​

​

000

2 of 51

Goals

  • Define Epidemiology
  • Discuss metrics of epidemiology
    • Measures of disease
    • Measures of effect
  • Describe basic study designs used in epidemiology
  • Discuss error, bias and confounding
  • Compare and contrast statistical models and dynamic models

​

​

​

​

2

3 of 51

Defining Epidemiology

“The study of the distribution and determinants of health-related states and events in populations, and the application of this study to control health problems.”

​

John M Last �Dictionary of Epidemiology

​

3

4 of 51

  • Risk Factors & Intervention Epidemiology�

4

Risk Factor: A characteristic that is correlated with a measure of disease.�

  • Often used synonymously with covariate.�
  • Protective factors: Risk factors that are negatively associated with disease

Varieties of Infectious Disease Epidemiology

5 of 51

Varieties of Infectious Disease Epidemiology

  • Risk Factors & Intervention �
  • Outbreak �

5

  • Clinical �
  • Surveillance

​

6 of 51

How does mathematical modeling fit?

  • Subfield: � Linking pattern with process across scales

6

�

  • Methodologies used in other epi subfields

​

Importance of knowledge breadth

7 of 51

Goals

  • Define Epidemiology
  • Discuss metrics of epidemiology
    • Measures of disease
    • Measures of effect
  • Describe basic study designs used in epidemiology
  • Discuss error, bias and confounding
  • Compare and contrast statistical models and dynamic models

​

​

​

​

7

8 of 51

Measures of Disease

  • Prevalence:
    • Proportion of the population with infection or disease at a given time point

​

  • Incidence:
    • The number of new cases that occur within a given population and period of time
    • Sometimes stated as a raw number of cases per time window, such as 1000 cases of influenza in a month
    • For comparison of incidence between populations (or within a population that is changing in size), incidence should be standardized (e.g., on a per capita basis or per 100,000 population per time period)

​

  • Survival �(time to event, e.g., death)

8

9 of 51

Measures of Covariates (risk factors)

  • Binary: smoker, circumcised��
  • Nominal/Categorical: geographic region��
  • Continuous: birth weight, T-cell count��
  • Ordinal: education, socioeconomic status (SES)�

9

10 of 51

Measures of Effect

  • How do you measure the effect of a risk factor on a disease?

​

​

Example

How could you measure whether circumcision influences the risk of HIV infection?�

10

11 of 51

Measures of Effect

11

    • Compare measure of disease across levels/values of risk factors �
    • Relative Risk - magnitude of association between risk factor & disease

​

    • Ratio of rates or proportions
        • Prevalence Ratio
        • Incidence rate Ratio
        • Odds Ratio

​

    • Attributable risk – public health impact of risk factor on disease

12 of 51

Goals

  • Define Epidemiology
  • Discuss metrics of epidemiology
    • Measures of disease
    • Measures of effect
  • Describe basic study designs used in epidemiology
  • Discuss error, bias and confounding
  • Compare and contrast statistical models and dynamic models

​

​

​

​

12

13 of 51

Epidemiological Studies

  • Descriptive Epidemiology
    • Baseline data on distribution of disease
    • Surveillance�
  • Analytic Epidemiology – Measure Effect
    • Ecological Studies
    • Cross-sectional Studies
    • Retrospective Case-Control Studies
    • Prospective Cohort Studies
    • Randomized Controlled Trials

​

  • Mathematical epidemiology
    • Mechanistically understand how the effects of risk factors lead to the distribution of disease

13

Observational

Experimental

Most studies are both

14 of 51

Ecological Studies

  • Measurements made at population rather than individual level.�
  • Weaker inference, but easier to gather data.

14

a.k.a

Correlational studies

15 of 51

15

Bousquet et al (2021) Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19. Allergy DOI: 10.1111/all.14549

​

16 of 51

Example

How could you measure whether circumcision influences the risk of HIV infection?�

​

16

17 of 51

Ecological study:�HIV prevalence (UNAIDS) vs�circumcision prevalence (DHS)

17

Williams et al. The Potential Impact of Male Circumcision on HIV in Sub-Saharan Africa. Plos Medicine 2006

Circumcision prevalence

HIV prevalence

18 of 51

Cross-Sectional Studies

  • Snapshot of diseases & risk factors.�
  • Cannot establish temporal relationship.�
  • Relatively cheap & easy.�
  • Population must be large to study rare disease.�
  • Not great for diseases of short duration. Why?

18

a.k.a

Surveys

Prevalence studies

19 of 51

Relative Risk: Prevalence Ratio

19

​

Disease

No Disease

Total (Margins)

Exposed

a

b

a+b

Not exposed

c

d

c+d

Total (Margins)

a+c

b+d

a+b+c+d

Prevalence Ratio (PR):�prevalence in exposed population divided by prevalence in unexposed population.

PR < 1 exposure correlates with reduced risk of disease

PR > 1 exposure correlates with increased risk of disease

​

 

Contingency table or 2x2 table:

20 of 51

Example

How could you measure whether circumcision influences the risk of HIV infection?�

​

20

21 of 51

Cross-sectional study:�HIV prevalence (DHS) vs�circumcision prevalence (DHS)�����SA 2016 DHS:

21

Njeuhmeli et al. Voluntary Medical Male Circumcision: Modeling the Impact and Cost of Expanding Male Circumcision for HIV Prevention in Eastern and Southern Africa. Plos Medicine 2011

​

HIV+

HIV-

Total

Circumcised

143

1121

1264

Not Circumcised

172

760

932

Total

315

1881

2196

 

22 of 51

Case-Control Studies

  • Compare diseased individuals to chosen controls.
    • Quality of study depends entirely on how controls are chosen.

​

  • Good for rare diseases.

​

  • Relatively cheap & quick.

22

23 of 51

Case Control Studies: Odds Ratios

23

​

Disease

No Disease

Total (Margins)

Exposed

a

b

a+b

Not exposed

c

d

c+d

Total (Margins)

a+c

b+d

a+b+c+d

Odds ratio is the ratio of odds in the diseased population divided by the odds in the �non-diseased population.

OR < 1 means exposure correlates with reduced risk of disease

OR > 1 means exposure correlates with increased risk of disease

​

Controls: Number chosen by researcher.

 

 

24 of 51

Example

How could you measure whether circumcision influences the risk of HIV infection?�

​

24

25 of 51

Case-control study:�

  • Sassan-Morokro et al, High rates of sexual contact with female sex workers, sexually transmitted diseases, and condom neglect among HIV-infected and uninfected men with tuberculosis in Abidjan, Cote d'Ivoire, JAIDS, 1996

​

​

​

​

25

​

HIV+

HIV-

Total

Circumcised

15

19

34

Not Circumcised

475

220

695

Total

490

239

729

 

​

HIV+

HIV-

Total

Circumcised

48

121

169

Not Circumcised

101

272

373

Total

149

393

542

 

  • Quigley et al. Sexual behaviour patterns and other risk factors for HIV infection in rural Tanzania: a case–control study, AIDS, 1997

​

​

​

​

26 of 51

Cohort Studies

  • Follow a selected population through time
    • Establishes temporal relationships
    • Can measure incidence�
  • Takes lots of resources, money, & time!�
  • Poor design for rare diseases.

26

a.k.a

Prospective studies

Longitudinal studies

Follow-up studies

27 of 51

27

28 of 51

Relative Risk: Cumulative Incidence Ratio

28

​

Disease

No Disease

Total (Margins)

Exposed

a

b

a+b

Not exposed

c

d

c+d

Total (Margins)

a+c

b+d

a+b+c+d

Cumulative Incidence Ratio (CIR):�cumulative incidence in exposed population divided by cumulative incidence in unexposed population.

CIR < 1 exposure correlates with reduced risk of disease

CIR > 1 exposure correlates with increased risk of disease

​

 

 

29 of 51

Cohort Data and Person-Time

X marks occurrence of disease X

O Marks death

Cumulative Incidence

Total number of person-time

Immunity

Time joining the study

Death

5 / 12 = 0.42

30 of 51

Cohort Data and Person-Time

X marks occurrence of disease X

O Marks death

Incidence rate

Number of disease occurrence

= 5

​

Total number of person-time (X confers immunity)

= 26 years

​

Incidence rate=5/26=0.19 per person year

31 of 51

Relative Risk: Incidence Rate Ratios

31

​

Disease

No Disease

Total (Margins)

Exposed

a

-

PYe

Not exposed

c

-

PY0

Total (Margins)

a+c

-

PYe + PY0

Incidence Rate Ratio is the ratio of the incidence rate of the exposed population to that of the unexposed population.

IRR < 1 means exposure correlates with reduced risk of disease

IRR > 1 means exposure correlates with increased risk of disease

​

 

32 of 51

Example

How could you measure whether circumcision influences the risk of HIV infection?�

​

32

33 of 51

Cohort study:�

33

Cameron et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. The Lancet 1989

​

HIV+

HIV-

Total Pwks

Circumcised

6

-

2966

Not circumcised

18

-

1016

Total (Margins)

24

-

3982

 

  • Nairobi, Kenya 1987
  • 293 clients of female sex workers (73% circumcised)
  • Mean follow-up of 14 weeks

34 of 51

Randomised Controlled Trials

  • Experimental or Intervention Studies�
  • Establishes temporal relationships�
  • Addresses confounding (more to come)

​

  • Causal evidence

​

  • Another in depth lecture on this follows!

34

35 of 51

Example

How could you measure whether circumcision influences the risk of HIV infection?�

​

35

36 of 51

Randomised Controlled Trial:�

36

Auvert et al. Randomized, Controlled Intervention Trial

of Male Circumcision for Reduction of HIV

Infection Risk: The ANRS 1265 Trial. Plos Medicine 2005

​

HIV+

HIV-

Total PYs

Circumcised

20

-

2,354

Not circumcised

49

-

2,339

Total (Margins)

69

-

4693

 

  • Johannesburg, SA 2003
  • 3274 men aged 18-24
  • Half circumcised at 0 months, other half offered at end

37 of 51

Goals

  • Define Epidemiology
  • Discuss metrics of epidemiology
    • Measures of disease
    • Measures of effect
  • Describe basic study designs used in epidemiology
  • Discuss error, bias and confounding
  • Compare and contrast statistical models and dynamic models

​

​

​

​

37

38 of 51

Random Error

  • How many people must be in a study for the measure of effect to believable?�

38

  • Statistical Approach:�Assign probabilities to our findings being a product of random error rather than a real phenomenon.

Estimate =

39 of 51

Bias

Difference between observed value and true value due to all causes other than random error.���

Bias does not go away with greater sample size!

​

​

Bias must be dealt with during study design!�

39

40 of 51

Selection Bias

Error due to systematic differences between those who take part in the study and those who do not.

John Last, Dictionary of Epidemiology�

40

Information Bias

A flaw in measuring exposure or outcome data that results in different quality (accuracy) of information between comparison groups.

John Last, Dictionary of Epidemiology�

�

41 of 51

Survivor Bias

41

42 of 51

42

Non-response Bias

43 of 51

Confounding

43

​

​

Literacy

​

​

HIV Status

​

HIV+

HIV-

Literate

660

340

Illiterate

180

820

What if some of the study population were much younger than others?

 

44 of 51

Confounding

44

Pooled

HIV+

HIV-

Literate

660

340

Illiterate

180

820

​

​

​

6-15 years old

HIV+

HIV-

Literate

30

270

Illiterate

90

810

​

​

​

16-24 years old

HIV+

HIV-

Literate

630

70

Illiterate

90

10

6-15 year olds: Literacy = 300/1200 = 25%�

16-24 year olds: Literacy = 700/800 = 87.5%

​

 

 

 

45 of 51

Confounding

45

​

​

Literacy

​

​

HIV Status

​

HIV+

HIV-

Literate

660

340

Illiterate

180

820

​

​

Age

​

​

CONFOUNDING

 

 

 

46 of 51

How do you deal with confounding?

  • Study Design
    • Randomize participants to treatment groups (RCTs)
    • Restrict participants to one group of the confounders

​

  • Study Analysis
    • Multivariable modeling statistically adjusts for effect of one risk factor, given the presence of a confounder
    • Stratification conducts a separate analysis for each level of the confounder

46

47 of 51

Goals

  • Define Epidemiology
  • Discuss metrics of epidemiology
    • Measures of disease
    • Measures of effect
  • Describe basic study designs used in epidemiology
  • Discuss error, bias and confounding
  • Compare and contrast statistical models and dynamic models

​

​

​

​

47

48 of 51

48

By developing dynamic models in a probabilistic framework, we can account for dependence, random error, and bias while linking patterns at multiple scales.

Statistical Models

Dynamical Models

  • Assume independence of individuals
  • Explicitly focus on inter-dependence of individuals (X transmitted disease to Y)
  • Account for random error and bias in data to assess relationships and find correlations that may imply causality
  • Explicitly model (hypothetically ‘declare’) specific mechanisms, to explore their interactions

49 of 51

Questions in Epidemiology

  • Is male circumcision effective against HIV acquisition?

49

Statistical Models

Dynamic Models

  • By how much would population level HIV incidence decrease if we circumcise 50% of all men?

50 of 51

Summary

  • Epidemiology seeks to measure and understand the causes of disease
  • Epidemiologists conduct observational and experimental studies to obtain data
    • Incidence and prevalence
    • RR’s, OR’s, attributable risk
  • Epidemiological studies are subject to bias, confounding, and variability
  • Traditionally, focus on discovering correlations that may lead to identification of causal factors
  • Dynamic models, informed via epidemiologic studies, can answer questions traditional studies can’t

​

50

51 of 51

Title: Study Design and Analysis in Epidemiology: Where does modelling fit?

https://figshare.com/collections/International_Clinics_on_Infectious_Disease_Dynamics_and_Data/3788224

000

000

000

000

This presentation is made available through a Creative Commons Attribution-Noncommercial license. Details of the license and permitted uses are available at� http://creativecommons.org/licenses/by/3.0/

​

Attribution:

​

Clinic on the Meaningful Modeling of Epidemiological Data

Source URL:

​

For further information please contact figshare@ici3d.org.

© 2014-2021 International Clinics on Infectious Disease Dynamics and Data